Sign In
Buy ZLDPF
$49.02
+0 (+0%)
At Close: Jun 03, 2026
Is Zealand Pharma AS (ZLDPF) Stock Undervalued Right Now?
10:41am, Tuesday, 12'th May 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Zealand Pharma A/S (ZLDPY) Q1 2026 Earnings Call Transcript
02:51pm, Thursday, 07'th May 2026
Zealand Pharma A/S (ZLDPY) Q1 2026 Earnings Call Transcript
Zealand Pharma A/S (ZLDPF) Reports Q1 Loss, Lags Revenue Estimates
08:10am, Thursday, 07'th May 2026
Zealand Pharma A/S (ZLDPF) came out with a quarterly loss of $0.87 per share versus the Zacks Consensus Estimate of a loss of $1.57. This compares to a loss of $0.67 per share a year ago.
Zealand Pharma posts smaller-than-expected Q1 loss as obesity drugs advance
01:10am, Thursday, 07'th May 2026
Danish drug developer Zealand Pharma reported a smaller-than-expected first-quarter operating loss on Thursday, boosted by strong momentum in its obesity drug pipeline, �
Comparing Brainstorm Cell Therapeutics (NASDAQ:BCLI) and Zealand Pharma A/S (OTCMKTS:ZLDPF)
04:10am, Saturday, 18'th Apr 2026
Brainstorm Cell Therapeutics (NASDAQ: BCLI - Get Free Report) and Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) are both medical companies, but which is the superior business? We will contrast
Zealand Pharma A/S (OTCMKTS:ZLDPF) Given Consensus Recommendation of “Moderate Buy” by Brokerages
04:49am, Thursday, 02'nd Apr 2026
Shares of Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the eight brokerages that are covering the stock, MarketBeat reports. Five e
Zealand Pharma A/S (ZLDPF) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
04:22pm, Wednesday, 11'th Mar 2026
Zealand Pharma A/S (ZLDPF) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Disappointing weight-loss-trial results from Zealand Pharma sends shares tumbling
08:52am, Friday, 06'th Mar 2026
Zealand Pharma obesity drug showed disappointing weight loss in a Phase 2 trial.
Roche, Zealand Pharma Obesity Drug Hits Goal in Midstage Trial
03:19am, Friday, 06'th Mar 2026
The company said the data supported further development of the drug in chronic weight management on its own or in combination with other drugs due to its tolerability.
Zealand Pharma A/S (ZLDPF) Discusses Top Line Phase II Results for ZUPREME-1 Trial of Petrelintide in Obesity Transcript
08:25pm, Thursday, 05'th Mar 2026
Zealand Pharma A/S (ZLDPF) Discusses Top Line Phase II Results for ZUPREME-1 Trial of Petrelintide in Obesity Transcript
Zealand Pharma A/S (ZLDPF) Q4 2025 Earnings Call Transcript
01:25pm, Thursday, 19'th Feb 2026
Zealand Pharma A/S (ZLDPF) Q4 2025 Earnings Call Transcript
Strength Seen in Zealand Pharma AS (ZLDPF): Can Its 6.8% Jump Turn into More Strength?
08:36am, Friday, 23'rd Jan 2026
Zealand Pharma AS (ZLDPF) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the nea
Zealand Pharma A/S (ZLDPF) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
07:05pm, Wednesday, 14'th Jan 2026
Zealand Pharma A/S (ZLDPF) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Zealand Pharma A/S (ZLDPF) Analyst/Investor Day Transcript
03:59pm, Monday, 15'th Dec 2025
Zealand Pharma A/S (ZLDPF) Analyst/Investor Day Transcript
Zealand Pharma to accelerate drug development for obesity, metabolic disease
01:35am, Thursday, 11'th Dec 2025
Danish biotech Zealand Pharma said on Thursday it will accelerate development and expand its research as it seeks to differentiate its experimental obesity drug candidates in an increasingly competiti
